These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer. Zhang Z, Zhang H, Li C, Xiang Q, Xu L, Liu Q, Pang X, Zhang W, Zhang H, Zhang S, Duan X, Liu Y, Cui Y. Thorac Cancer; 2021 Dec; 12(24):3396-3406. PubMed ID: 34751517 [Abstract] [Full Text] [Related]
25. Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial. Stevic I, Müller V, Weber K, Fasching PA, Karn T, Marmé F, Schem C, Stickeler E, Denkert C, van Mackelenbergh M, Salat C, Schneeweiss A, Pantel K, Loibl S, Untch M, Schwarzenbach H. BMC Med; 2018 Oct 10; 16(1):179. PubMed ID: 30301470 [Abstract] [Full Text] [Related]
27. Quantitative and Specific Detection of Exosomal miRNAs for Accurate Diagnosis of Breast Cancer Using a Surface-Enhanced Raman Scattering Sensor Based on Plasmonic Head-Flocked Gold Nanopillars. Lee JU, Kim WH, Lee HS, Park KH, Sim SJ. Small; 2019 Apr 10; 15(17):e1804968. PubMed ID: 30828996 [Abstract] [Full Text] [Related]
29. Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers. Swellam M, Ramadan A, El-Hussieny EA, Bakr NM, Hassan NM, Sobeih ME, EzzElArab LR. J Cell Biochem; 2019 Aug 10; 120(8):12321-12330. PubMed ID: 30825229 [Abstract] [Full Text] [Related]
32. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. McGuire A, Brown JA, Kerin MJ. Cancer Metastasis Rev; 2015 Mar 10; 34(1):145-55. PubMed ID: 25721950 [Abstract] [Full Text] [Related]
33. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma. Lee YR, Kim G, Tak WY, Jang SY, Kweon YO, Park JG, Lee HW, Han YS, Chun JM, Park SY, Hur K. Int J Cancer; 2019 Mar 15; 144(6):1444-1452. PubMed ID: 30338850 [Abstract] [Full Text] [Related]
35. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing. Jin X, Chen Y, Chen H, Fei S, Chen D, Cai X, Liu L, Lin B, Su H, Zhao L, Su M, Pan H, Shen L, Xie D, Xie C. Clin Cancer Res; 2017 Sep 01; 23(17):5311-5319. PubMed ID: 28606918 [Abstract] [Full Text] [Related]
37. Cancer-derived exosomal miR-7641 promotes breast cancer progression and metastasis. Shen S, Song Y, Zhao B, Xu Y, Ren X, Zhou Y, Sun Q. Cell Commun Signal; 2021 Feb 22; 19(1):20. PubMed ID: 33618729 [Abstract] [Full Text] [Related]
39. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer. Li M, Zhou Y, Xia T, Zhou X, Huang Z, Zhang H, Zhu W, Ding Q, Wang S. Breast Cancer Res Treat; 2018 Jul 22; 170(2):257-270. PubMed ID: 29557526 [Abstract] [Full Text] [Related]